Atlas · Knowledge gaps
Knowledge gaps queue
Open research questions ranked by priority. Each gap is a candidate for a debate or a SPEC-033 bounty challenge.
4
open gaps
| # | Title | Status | Priority | Domain | Created | |
|---|---|---|---|---|---|---|
| 1 | How does genetic variation determine the genotype-dependent response variabilit… The abstract mentions that Atremorine response is genotype-dependent but doesn't specify which genetic variants influence efficacy. This pharmacogenomic gap lim… gap-pubmed-20260410-145531-82b27dc7 | open | 0.820 | pharmacogenomics | 2026-04-10 | Open → |
| 2 | What are the specific molecular mechanisms by which miR-375 orchestrates pharma… The abstract establishes that miR-375 protects against acetaminophen-induced liver failure by orchestrating pharmacogene expression, but the precise molecular p… gap-pubmed-20260410-155356-a8a8fad3 | open | 0.820 | pharmacogenomics | 2026-04-10 | Open → |
| 3 | How does tissue-specific chromatin context influence therapeutic targeting of m… The Skeptic raised concerns about tissue-specific chromatin landscapes affecting therapeutic responses, but this wasn't addressed in the MECI hypothesis evaluat… gap-debate-20260410-095952-d06c9d01 | open | 0.820 | pharmacogenomics | 2026-04-10 | Open → |
| 4 | How do >30 defective pharmagene variants per patient mechanistically interact t… The abstract reports that >50% of AD patients have >30 defective variants across pharmagenes, but doesn't explain how these variants interact mechanistically. U… gap-pubmed-20260410-145347-1916f77e | open | 0.780 | pharmacogenomics | 2026-04-10 | Open → |